查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1705884

全球供应商中立檔案 (VNA) 市场按部署模式、供应商类型、影像类型、最终用户和地区划分

Global Vendor Neutral Archive (VNA) Market, By Deployment Model, By Vendor Type, By Imaging Type, By End User, By Geography
出版日期: | 出版商: Coherent Market Insights | 英文 172 Pages | 商品交期: 2-3个工作天内

价格
简介目录

预计 2025 年全球供应商中立檔案 (VNA) 市场规模将达到 39.6 亿美元，到 2032 年将达到 57.3 亿美元，2025 年至 2032 年的年复合成长率（CAGR）为 5.4%。

报告范围 报告详细信息
基准年 2024 2025年的市场规模 39.6亿美元
效能数据 从2020年到2024年 预测期 2025年至2032年
预测期：2025-2032年复合年增长率： 5.40% 2032年价值预测 57.3亿美元
数字。 2025 年全球市场占有率（按地区）
全球供应商中立檔案（VNA）市场-IMG1

供应商中立檔案 (VNA) 是一种影像管理解决方案，可让任何医疗保健应用程式从多个来源和模式储存、查询和搜寻医疗图像和相关报告。传统上，医疗保健组织必须管理多个 PACS 系统来储存和存取放射影像，这增加了成本和技术复杂性。 VNA 提供了一个中央储存库，将来自所有部门、资讯来源和专业的影像资料整合到一个檔案中。这将促进互通性、普遍可近性和优化的医疗保健合作。

市场动态：

推动供应商中立檔案 (NVA) 市场成长的因素包括：由于慢性病的流行导致影像处理不断增加、对医学影像集中储存系统的偏好日益增长，以及在各种医疗保健环境中改善资料共用和加强患者照护协调的需求。然而，安装和维护 VNA 的成本高昂，而且缺乏专业知识（尤其是在较小的医疗机构中），限制了它们的广泛应用。同时，远端医疗实践的扩展、实现人工智慧整合的技术进步以及预测分析为供应商提供了丰厚的机会。

本研究的主要特点

  • 本研究报告对全球供应商中立檔案 (VNA) 市场进行了详细分析，并提供了预测期 (2025-2032) 的市场规模和年复合成长率(CAGR)，假设 2024 年为基准年。
  • 它还强调了各个领域的潜在收益成长机会，并说明了该市场的引人注目的投资提案矩阵。
  • 它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景和主要企业采用的竞争策略的主要考察。
  • 该报告根据公司亮点、产品系列、关键亮点、财务绩效和策略等参数涵盖了全球供应商中立檔案 (VNA) 市场的主要企业的概况。
  • 本报告的见解将使负责人和企业经营团队能够就未来的产品发布、新兴趋势、市场扩张和行销策略做出明智的决策。
  • 全球供应商中立檔案 (VNA) 市场报告针对该行业的各个相关人员，包括投资者、供应商、产品製造商、经销商、新进业者和金融分析师。
  • 相关人员可以透过用于分析全球供应商中立檔案 (VNA) 市场的各种策略矩阵来更轻鬆地做出决策。

目录

第一章 调查目的与前提条件

  • 研究目标
  • 先决条件
  • 简称

第二章 市场展望

  • 报告描述
    • 市场定义和范围
  • 执行摘要
  • Coherent Opportunity Map（COM）

第三章市场动态、法规与趋势分析

  • 市场动态
  • 影响分析
  • 主要亮点
  • 监管情景
  • 服务产品组合
  • PEST分析
  • 波特分析
  • 併购场景
  • 管道分析

第四章 全球供应商中立檔案（VNA）市场-冠状病毒（COVID-19）大流行的影响

  • COVID-19流行病学
  • 供需侧分析
  • 经济影响

5. 2020 年至 2032 年全球供应商中立檔案 (VNA) 市场（依部署模式）

  • 本地 VNA
  • 云端基础的VNA

6. 2020 年至 2032 年按供应商类型分類的供应商中立檔案 (VNA) 市场

  • 独立软体供应商 (ISV)
  • PACS供应商
  • 基础设施供应商

7. 2020 年至 2032 年全球供应商中立檔案 (VNA) 市场（按图像类型）

  • 放射学 VNA
  • 心臟病学 VNA
  • 病理学VNA

8. 2020 年至 2032 年全球供应商中立檔案 (VNA) 市场（依最终使用者划分）

  • 医院
  • 诊断影像中心
  • 门诊治疗中心
  • 研究和学术机构

9. 2020 年至 2032 年全球供应商中立檔案 (VNA) 市场（按地区）

  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东
  • 非洲

第十章 竞争格局

  • Johnson & Johnson Private Limited
  • Merck & Co., Inc.
  • F. Hoffmann-La Roche Ltd.
  • Baxter
  • Bayer AG
  • Eli Lilly and Company
  • Sun Pharmaceutical Industries Ltd.
  • Aurobindo Pharma
  • Lupin
  • Allergan
  • AbbVie Inc.
  • Abbott
  • Bausch Health Companies Inc.
  • Pfizer Inc.
  • GlaxoSmithKline plc
  • Novartis AG
  • Mylan NV
  • Teva Pharmaceutical Industries Ltd.
  • Sanofi
  • AstraZeneca

第 11 章 章节

  • 调查方法
  • 关于出版商
简介目录
Product Code: CMI6654

Global Vendor Neutral Archive (VNA) Market is estimated to be valued at USD 3.96 Bn in 2025 and is expected to reach USD 5.73 Bn by 2032, growing at a compound annual growth rate (CAGR) of 5.4% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 3.96 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 5.40% 2032 Value Projection: USD 5.73 Bn
Figure. Global Vendor Neutral Archive (VNA) Market Share (%), By Region 2025
Global Vendor Neutral Archive (VNA) Market - IMG1

Vendor neutral archive (VNA) is an image management solution that allows medical images and associated reports to be stored, queried, and retrieved by any healthcare application from multiple sources and modalities. Traditionally, healthcare organizations have had to manage multiple PACS systems to store and access radiology images which led to increased costs and technological complexities. A VNA provides a central repository that consolidates imaging data from all departments, sources, and specialties in a single archive. This facilitates interoperability, universal access, and optimized care collaboration.

Market Dynamics:

The growth of the vendor neutral archive (VNA) market is driven by factors such as rising imaging volumes due to increasing prevalence of chronic diseases, growing preferences for centralized medical imaging storage systems, and need to improve data sharing and enhance patient care coordination across various care delivery settings. However, high costs associated with the deployment and maintenance of VNAs as well as lack of expertise especially in small healthcare facilities limit their widespread adoption. Meanwhile, growing telehealth practices, technological advancements to enable artificial intelligence integration, and predictive analytics present lucrative opportunities for vendors.

Key features of the study:

  • This report provides an in-depth analysis of the global vendor neutral archive (VNA) market, and provides market size (US$ Billion) and compound annual growth rate (CAGR %) for the forecast period (2025-2032), considering 2024 as the base year
  • It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global vendor neutral archive (VNA) market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Johnson & Johnson Private Limited, Merck & Co., Inc., F. Hoffmann-La Roche Ltd., Baxter, Bayer AG, Eli Lilly and Company, Sun Pharmaceutical Industries Ltd., Aurobindo Pharma, Lupin , Allergan, AbbVie Inc., Abbott, Bausch Health Companies Inc. , Pfizer Inc., GlaxoSmithKline plc, Novartis AG, Mylan N.V., Teva Pharmaceutical Industries Ltd., Sanofi, and AstraZeneca
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global vendor neutral archive (VNA) market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global vendor neutral archive (VNA) market

Detailed Segmentation:

  • Global Vendor Neutral Archive (VNA) Market, By Deployment Model
    • On-Premise VNA
    • Cloud-Based VNA
  • Global Vendor Neutral Archive (VNA) Market, By Vendor Type
    • Independent Software Vendors (ISVs)
    • PACS Vendors
    • Infrastructure Vendors
  • Global Vendor Neutral Archive (VNA) Market, By Imaging Type
    • Radiology VNAs
    • Cardiology VNAs
    • Pathology VNAs
  • Global Vendor Neutral Archive (VNA) Market, By End-User
    • Hospitals
    • Diagnostic Imaging Centers
    • Ambulatory Care Centers
    • Research and Academic Institutes
  • Global Vendor Neutral Archive (VNA) Market, By Region
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profiles
    • Johnson & Johnson Private Limited
    • Merck & Co., Inc.
    • F.Hoffmann-La Roche Ltd.
    • Baxter
    • Bayer AG
    • Eli Lilly and Company
    • Sun Pharmaceutical Industries Ltd.
    • Aurobindo Pharma
    • Lupin
    • Allergan
    • AbbVie Inc.
    • Abbott
    • Bausch Health Companies Inc.
    • Pfizer Inc.
    • GlaxoSmithKline plc
    • Novartis AG
    • Mylan N.V.
    • Teva Pharmaceutical Industries Ltd.
    • Sanofi
    • AstraZeneca

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global Vendor Neutral Archive (VNA) Market, By Deployment Model
    • Global Vendor Neutral Archive (VNA) Market, By Vendor Type
    • Global Vendor Neutral Archive (VNA) Market, By Imaging Type
    • Global Vendor Neutral Archive (VNA) Market, By End User
    • Global Vendor Neutral Archive (VNA) Market, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Increasing adoption of cloud-based VNA solutions
    • Growing adoption of imaging equipment across healthcare facilities
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Service Offering Portfolio
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario
  • Pipeline Analysis

4. Global Vendor Neutral Archive (VNA) Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global Vendor Neutral Archive (VNA) Market, By Deployment Model, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • On-premise VNA
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Cloud-based VNA
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

6. Global Vendor Neutral Archive (VNA) Market, By Vendor Type, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Independent Software Vendors (ISVs)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • PACS Vendors
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Infrastructure Vendors
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

7. Global Vendor Neutral Archive (VNA) Market, By Imaging Type, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Radiology VNAs
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Cardiology VNAs
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Pathology VNAs
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

8. Global Vendor Neutral Archive (VNA) Market, By End User, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Diagnostic Imaging Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Ambulatory Care Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Research and Academic Institutes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

9. Global Vendor Neutral Archive (VNA) Market, By Region, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, By Region, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, For Region, 2021 - 2032
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Deployment Model, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Vendor Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Imaging Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    • U.S.
    • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Deployment Model, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Vendor Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Imaging Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Deployment Model, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Vendor Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Imaging Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Deployment Model, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Vendor Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Imaging Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Deployment Model, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Vendor Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Imaging Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Deployment Model, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Vendor Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Imaging Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Sub-region, 2020-2032,(US$ Bn)
      • North Africa
      • Central Africa
      • South Africa

10. Competitive Landscape

  • Johnson & Johnson Private Limited
    • Company Highlights
    • Deployment Model Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Merck & Co., Inc.
  • F. Hoffmann-La Roche Ltd.
  • Baxter
  • Bayer AG
  • Eli Lilly and Company
  • Sun Pharmaceutical Industries Ltd.
  • Aurobindo Pharma
  • Lupin
  • Allergan
  • AbbVie Inc.
  • Abbott
  • Bausch Health Companies Inc.
  • Pfizer Inc.
  • GlaxoSmithKline plc
  • Novartis AG
  • Mylan N.V.
  • Teva Pharmaceutical Industries Ltd.
  • Sanofi
  • AstraZeneca
  • Analyst Views

11. Section

  • Research Methodology
  • About us